37551 |
Oncology |
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell L... |
CANCER RES TREAT 2020 10.4143/crt.2020.278 |
선종무 |
2020 |
37550 |
Oncology |
Clinical outcomes of immune checkpoint inhibitors for patients with re... |
BMC CANCER 2020 10.1186/s12885-020-07214-4 |
선종무 |
2020 |
37549 |
Oncology; Immunology |
Clinical advantage of targeted sequencing for unbiased tumor mutationa... |
J IMMUNOTHER CANCER 2020 10.1136/jitc-2020-001199 |
선종무 |
2020 |
37548 |
Oncology |
Biomarker-driven phase 2 umbrella trial study for patients with recurr... |
CANCER 2020 10.1002/cncr.33048 |
선종무 |
2020 |
37547 |
Oncology |
A phase II, multicenter, two cohort study of 160 mg osimertinib in EGF... |
ANN ONCOL 2020 10.1016/j.annonc.2020.06.017 |
선종무 |
2020 |
37546 |
Respiratory System |
Are there any ethnic differences in the efficacy and safety of immune ... |
J THORAC DIS 2020 10.21037/jtd.2019.08.29 |
선종무 |
2020 |
37545 |
Oncology |
Severe cytomegalovirus gastritis after pembrolizumab in a patient with... |
CURR ONCOL 2020 10.3747/co.27.6163 |
이지연 |
2020 |
37544 |
Oncology; Gastroenterology & Hepatology |
Prognostic significance of sarcopenia in microsatellite-stable gastric... |
GASTRIC CANCER 2020 10.1007/s10120-020-01124-x |
이지연 |
2020 |
37543 |
Biochemistry & Molecular Biology; Medicine, Research & Experimental |
Tumor-promoting macrophages prevail in malignant ascites of advanced g... |
EXP MOL MED 2020 10.1038/s12276-020-00538-y |
이지연 |
2020 |
37542 |
Genetics & Heredity |
Single-cell transcriptome analysis of tumor and stromal compartments o... |
GENOME MED 2020 10.1186/s13073-020-00776-9 |
이지연 |
2020 |